Product containing citric acid and magnesium oxide and sodium picosulfate (medicinal product)
RxNorm 1304093
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1304093 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Product containing citric acid and magnesium oxide and sodium picosulfate (medicinal product).
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
MINPrescribable
Multiple Ingredients (MIN):
Citric acid / magnesium oxide / picosulfurate
(Atom ID: 12352653)
PTPrescribable
Designated preferred name (PT):
Citric acid- and magnesium oxide- and sodium picosulfate-containing product
(Atom ID: 10799882)
FNPrescribable
Full form of descriptor (FN):
Product containing citric acid and magnesium oxide and sodium picosulfate (medicinal product)
(Atom ID: 10305490)
Patient Education
Sodium Picosulfate, Magnesium Oxide, and Anhydrous Citric Acid
Sodium picosulfate, magnesium oxide, and anhydrous citric acid is used in adults and children 9 years of age and older to empty the colon (large intestine, bowel) before a colonoscopy (examination of the inside of the colon to check for colon cancer and other abnormalities) so that the doctor will have a clear view of the walls of the colon. Sodium picosulfate is in a class of medications called stimulant laxatives. Magnesium oxide and anhydrous citric acid combine to form a medication called magnesium citrate. Magnesium citrate is in a class of medications called osmotic laxatives. These medications work by causing watery diarrhea so that the stool can be emptied from the colon.
[Learn More]
Magnesium
[Learn More]
* Please review the disclaimer below.